167 related articles for article (PubMed ID: 7219797)
1. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].
Di Nola F; Eandi M; Soranzo ML; Capra E; Bosio G; Bramato C; Salassa B; Bendiscioli L
Minerva Med; 1981 Apr; 72(14):875-92. PubMed ID: 7219797
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic and clinical research on a new aminoglycoside antibiotic: sisomicin].
Di Nola F; Soranzo ML; Bosio G; Sachelariu N; Guasco C; Bendiscioli L; Bisarello I
Minerva Med; 1978 Sep; 69(43):2951-62. PubMed ID: 714275
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and experimental rifampicin passage through the hemato-encephalic barrier and its effectiveness in treating meningococcal infections].
Ivanov KS; Verovaia AV; Dergunova GA; Duiunov VM; Popova NN
Antibiotiki; 1981 May; 26(5):383-8. PubMed ID: 7259147
[TBL] [Abstract][Full Text] [Related]
4. [Pathogen spectrum in bacterial meningitis in childhood and subsequent therapeutic strategy].
Wässer S; Spencker FB; Handrick W; Rieske K; Lietz R; Springer W
Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):467-74. PubMed ID: 3685207
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin for treatment of bacterial meningitis.
Gump DW
Rev Infect Dis; 1981; 3 suppl():S289-92. PubMed ID: 6896243
[TBL] [Abstract][Full Text] [Related]
6. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
Eule H; Werner E; Winsel K; Iwainsky H
Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
[No Abstract] [Full Text] [Related]
8. Rifampicin, a general review.
Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
[No Abstract] [Full Text] [Related]
9. [Serum and cerebrospinal fluid levels of rifampicin (R AMP)].
Larbaoui D; Boulahbal F; Ait-Khaled A; Baghbagha D; Benseman H; Bensafar SA
Arch Inst Pasteur Alger; 1972-1973; 50-51():171-81. PubMed ID: 4681630
[No Abstract] [Full Text] [Related]
10. On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patients.
Iwainsky H; Winsel K; Werner E; Eule H
Scand J Respir Dis; 1976; 57(1):5-11. PubMed ID: 1273544
[TBL] [Abstract][Full Text] [Related]
11. [Suppurative meningitis in adults due to rare species of the causative agent].
Lisukova TE; Os'kina VV; Kashin AM; Lazukina LI; Il'ina TV
Ter Arkh; 1988; 60(11):57-60. PubMed ID: 3238578
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
[TBL] [Abstract][Full Text] [Related]
13. [Association of hetacillin and dicloxacillin in 4:3 ratio. Pharmacological research, in-vitro activity and clinical use].
Di Nola F; Salassa MR; Cerutti L; Soranzo ML; Bosio G; Pasquale A; Grillone W; Sardi P
Minerva Med; 1973 Nov; 64(82):4332-48. PubMed ID: 4587772
[No Abstract] [Full Text] [Related]
14. [Clinical experiences with intravenous immunoglobulin therapy of infectious diseases in infancy and childhood].
Gyarmati E; Nyerges G; Hajdi G; Pataki M
Padiatr Padol; 1983; 18(3):281-9. PubMed ID: 6888948
[TBL] [Abstract][Full Text] [Related]
15. Parenteral rifampicin in tuberculous and severe non-mycobacterial infections. Clinical data on 237 patients.
Kissling M; Bergamini N; Xilinas M
Chemotherapy; 1982; 28(3):229-39. PubMed ID: 7094664
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory brain diseases in clinical practice].
Lungwitz J; Voigt W
Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):321-30. PubMed ID: 6484057
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
[TBL] [Abstract][Full Text] [Related]
18. [Passage of rifampicin through the hemato-liquor barrier].
Rossolini A; Mattei C; Bianchini AM
Minerva Pediatr; 1972 Aug; 24(28):1170-4. PubMed ID: 4639063
[No Abstract] [Full Text] [Related]
19. [Use of an injectable form of rifampicin in severe banal pyogenic infections in a resuscitation setting].
Wattel F; Martin G; Durocher A; Courcol R; Fourrier F; Fruchart A; Dubois D; Mathieu D
LARC Med; 1982 Oct; 2(9):812-6, 819. PubMed ID: 7162285
[No Abstract] [Full Text] [Related]
20. [Kinetic and clinical study of bacampicillin].
Di Nola F; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Andreoni G; Eandi M; Musso E
Minerva Med; 1981 Apr; 72(15):941-50. PubMed ID: 7219802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
